文献速递心脑血管急症

Notch3信号通路调控主动脉夹层血管干细胞向平滑肌细胞分化的机制

[Mechanism of Notch3 signaling pathway regulating the differentiation of aortic dissection vascular stem cells into smooth muscle cells].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2023-01-01
一句话结论主动脉夹层来源血管干细胞向平滑肌细胞分化失调,Notch3通路激活参与其中,体外抑制Notch3可恢复收缩蛋白表达。

该研究从主动脉夹层患者及心脏移植供体获取主动脉组织,用酶消化和c-kit免疫磁珠分离血管干细胞,并以转化生长因子-β1(10 μg/L)诱导7天建立向平滑肌细胞分化模型。结果显示夹层主动脉中膜收缩标志物α-SMA、CNN1表达下调而NICD3上调;夹层来源血管干细胞分化后收缩标志物下调、NICD3明显上调;加入Notch3抑制剂DAPT(20 μmol/L)后α-SMA、CNN1表达回升。提示夹层中血管干细胞向平滑肌细胞分化失调,抑制Notch3通路激活可恢复收缩蛋白表达。

要点

  • 夹层主动脉中膜α-SMA/β-actin为0.40±0.12、CNN1/β-actin为0.78±0.07,低于正常供体的1.00±0.11、1.00±0.14(均P<0.05)。
  • 夹层主动脉NICD3/GAPDH为2.22±0.57,高于正常供体的1.00±0.15(P<0.05)。
  • 夹层来源血管干细胞分化后α-SMA、CNN1下调(0.35±0.13 vs. 1.00±0.20、0.78±0.06 vs. 1.00±0.07,均P<0.05),NICD3上调(22.32±1.22 vs. 1.00±0.06,P<0.01)。
  • 分化诱导时加入DAPT 20 μmol/L后,α-SMA、CNN1回升(1.70±0.07 vs. 1.00±0.15、1.62±0.03 vs. 1.00±0.02,均P<0.05)。

适用人群与场景

  • 于南方医科大学附属广东省人民医院心血管外科接受主动脉血管置换的主动脉夹层患者,以及心脏移植供体。

处置流程与药物剂量

  • 体外以转化生长因子-β1 10 μg/L诱导血管干细胞向平滑肌细胞分化7天。
  • 分化诱导时加入Notch3抑制剂DAPT 20 μmol/L。

研究设计与关键结果

  • 研究类型为实验室细胞与组织研究;组织来自主动脉夹层患者和心脏移植供体,分为正常供体来源血管干细胞组(Ctrl-VSC组)与夹层来源血管干细胞组(AD-VSC组)。
  • 免疫组化显示主动脉外膜存在c-kit阳性血管干细胞,正常供体与夹层患者的血管干细胞均能向脂肪细胞和软骨细胞分化。
  • 与正常供体血管组织比较,夹层中膜收缩标志物α-SMA/β-actin为0.40±0.12 vs. 1.00±0.11、CNN1/β-actin为0.78±0.07 vs. 1.00±0.14,均下调(均P<0.05);NICD3/GAPDH为2.22±0.57 vs. 1.00±0.15,上调(P<0.05)。
  • 与Ctrl-VSC-SMC组比较,AD-VSC-SMC组α-SMA/β-actin为0.35±0.13 vs. 1.00±0.20、CNN1/β-actin为0.78±0.06 vs. 1.00±0.07,均下调(均P<0.05);NICD3/GAPDH为22.32±1.22 vs. 1.00±0.06,上调(P<0.01)。
  • 与AD-VSC-SMC组比较,AD-VSC-SMC+DAPT组α-SMA/β-actin为1.70±0.07 vs. 1.00±0.15、CNN1/β-actin为1.62±0.03 vs. 1.00±0.02,均上调(均P<0.05)。

证据类型、等级与局限

  • 证据类型:实验室细胞与组织研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,主动脉夹层中存在血管干细胞向平滑肌细胞分化失调,抑制Notch3通路激活可恢复夹层血管干细胞来源平滑肌细胞的收缩蛋白表达。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To explore whether the differentiation of vascular stem cells (VSC) into smooth muscle cells (SMC) in aortic dissection (AD) is dysregulated, and to verify the role of Notch3 pathway in this process.

METHODS: Aortic tissues were obtained from AD patients undergoing aortic vascular replacement and heart transplant donors at Department of Cardiovascular Surgery, Guangdong Provincial People's Hospital Affiliated to Southern Medical University. VSC were isolated by enzymatic digestion and c-kit immunomagnetic beads. The cells were divided into normal donor-derived VSC group (Ctrl-VSC group) and AD-derived VSC group (AD-VSC group). The presence of VSC in the aortic adventitia was detected by immunohistochemical staining, and VSC was identified by stem cell function identification kit. The differentiation model of VSC into SMC established in vitro was induced by transforming growth factor-β1 (10 μg/L) for 7 days. They were divided into normal donor VSC-SMC group (Ctrl-VSC-SMC group), AD VSC-SMC group (AD-VSC-SMC group) and AD VSC-SMC+Notch3 inhibitor DAPT group (AD-VSC-SMC+DAPT group,DAPT 20 μmol/L was added during differentiation induction). The expression of contractile marker Calponin 1 (CNN1) in SMC derived from aortic media and VSC were detected by immunofluorescence staining. The protein expressions of contractile markers α-smooth muscle actin (α-SMA), CNN1 as well as Notch3 intracellular domain (NICD3) in SMC derived from aortic media and VSC were detected by Western blotting.

RESULTS: Immunohistochemical staining showed there was a population of c-kit-positive VSC in the adventitia of aortic vessels, and VSC from both normal donors and AD patients had the ability to differentiate into adipocytes and chondrocytes. Compared with normal donor vascular tissue, the expressions of SMC markers α-SMA and CNN1 of tunica media contraction in AD were down-regulated (α-SMA/β-actin: 0.40±0.12 vs. 1.00±0.11, CNN1/β-actin: 0.78±0.07 vs. 1.00±0.14, both P < 0.05), while the protein expression of NICD3 was up-regulated (NICD3/GAPDH: 2.22±0.57 vs. 1.00±0.15, P < 0.05). Compared with Ctrl-VSC-SMC group, the expressions of contractile SMC markers α-SMA and CNN1 were down-regulated in AD-VSC-SMC group (α-SMA/β-actin: 0.35±0.13 vs. 1.00±0.20, CNN1/β-actin: 0.78±0.06 vs. 1.00±0.07, both P < 0.05), the protein expression of NICD3 was up-regulated (NICD3/GAPDH: 22.32±1.22 vs. 1.00±0.06, P < 0.01). Compared with AD-VSC-SMC group, the expressions of contractile SMC markers α-SMA, CNN1 were up-regulated in AD-VSC-SMC+DAPT group (α-SMA/β-actin: 1.70±0.07 vs. 1.00±0.15, CNN1/β-actin: 1.62±0.03 vs. 1.00±0.02, both P < 0.05).

CONCLUSIONS: Dysregulation of VSC differentiation into SMC occurs in AD, while inhibition of Notch3 pathway activation can restore the expression of contractile proteins in VSC-derived SMC in AD.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Han Y, He H, Li X, et al. [Mechanism of Notch3 signaling pathway regulating the differentiation of aortic dissection vascular stem cells into smooth muscle cells]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2023. PMID: 37308231. doi:10.3760/cma.j.cn121430-20230131-00052

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。